|
Under the National Blood Agreement one of the primary policy objectives for the NBA is to undertake national information gathering, monitoring of new developments, reporting and research in relation to the Australian Blood sector.
The NBA is progressively putting in place various systems and processes to collate and report on data collected on products issued to Blood Product Recipients. The NBA is committed to sharing this information with the Australian community. The publication of these data and graphs on our website is part of this process.
Further data and graphs will be made available on the website as they become available.
Questions or issues in relation to the data and graphs provided in the attached document should be directed to Ms Sandra Cochrane, Director Strategic Data and Supply Management by telephone at (02) 62118359 or by email to .
Feedback | Privacy | Copyright | Disclaimer | Contact Us
This page last modified on February 10, 2009Criteria for the Clinical Use of Intravenous Immunoglobulin (IVIg)
Public Consultation: Imported Plasma & Recombinant Products
Request for Tender
- National Managed Fund Management and Advice Services
Employment Opportunities
- ICT Project Manager
- EL1 Scientist/Writer/Researcher
- EL2 Chief Financial Officer
Blood Supply to Australians Overseas
NBA Newsfeed
Subscribe to RSS
-- What is RSS?